nodes	percent_of_prediction	percent_of_DWPC	metapath
Orlistat—PLA2G7—Synthesis, secretion, and deacylation of Ghrelin—KLF4—germ cell cancer	0.0451	0.294	CbGpPWpGaD
Orlistat—ABHD12—optic choroid—germ cell cancer	0.0365	0.0852	CbGeAlD
Orlistat—LIPF—pituitary gland—germ cell cancer	0.0154	0.0359	CbGeAlD
Orlistat—PLA2G7—Peptide hormone metabolism—INHA—germ cell cancer	0.014	0.091	CbGpPWpGaD
Orlistat—PLA2G7—Peptide hormone metabolism—KLF4—germ cell cancer	0.0124	0.0811	CbGpPWpGaD
Orlistat—PLA2G4A—Raltitrexed—Methotrexate—germ cell cancer	0.0118	1	CbGdCrCtD
Orlistat—LIPF—testis—germ cell cancer	0.0113	0.0265	CbGeAlD
Orlistat—ABHD16A—trigeminal ganglion—germ cell cancer	0.0091	0.0212	CbGeAlD
Orlistat—DAGLB—decidua—germ cell cancer	0.00893	0.0209	CbGeAlD
Orlistat—ABHD12—trigeminal ganglion—germ cell cancer	0.00852	0.0199	CbGeAlD
Orlistat—DAGLA—head—germ cell cancer	0.00757	0.0177	CbGeAlD
Orlistat—ABHD12—eye—germ cell cancer	0.00734	0.0171	CbGeAlD
Orlistat—DAGLA—testis—germ cell cancer	0.00731	0.0171	CbGeAlD
Orlistat—ABHD12—retina—germ cell cancer	0.00728	0.017	CbGeAlD
Orlistat—PLA2G7—decidua—germ cell cancer	0.00722	0.0169	CbGeAlD
Orlistat—FASN—trigeminal ganglion—germ cell cancer	0.00715	0.0167	CbGeAlD
Orlistat—DAGLB—adrenal gland—germ cell cancer	0.00686	0.016	CbGeAlD
Orlistat—ABHD16A—decidua—germ cell cancer	0.00677	0.0158	CbGeAlD
Orlistat—DAGLA—cerebellum—germ cell cancer	0.00675	0.0158	CbGeAlD
Orlistat—DAGLB—female gonad—germ cell cancer	0.00639	0.0149	CbGeAlD
Orlistat—ABHD12—decidua—germ cell cancer	0.00634	0.0148	CbGeAlD
Orlistat—PLA2G7—pituitary gland—germ cell cancer	0.0062	0.0145	CbGeAlD
Orlistat—PLA2G7—medulla oblongata—germ cell cancer	0.00598	0.014	CbGeAlD
Orlistat—ABHD16A—pituitary gland—germ cell cancer	0.00582	0.0136	CbGeAlD
Orlistat—DAGLB—testis—germ cell cancer	0.00567	0.0132	CbGeAlD
Orlistat—FASN—telencephalon—germ cell cancer	0.00562	0.0131	CbGeAlD
Orlistat—ABHD16A—medulla oblongata—germ cell cancer	0.00561	0.0131	CbGeAlD
Orlistat—PLA2G7—adrenal gland—germ cell cancer	0.00554	0.0129	CbGeAlD
Orlistat—DAGLA—brain—germ cell cancer	0.00549	0.0128	CbGeAlD
Orlistat—PLA2G7—midbrain—germ cell cancer	0.00547	0.0128	CbGeAlD
Orlistat—ABHD12—pituitary gland—germ cell cancer	0.00545	0.0127	CbGeAlD
Orlistat—PNLIP—pituitary gland—germ cell cancer	0.00545	0.0127	CbGeAlD
Orlistat—PLA2G7—bone marrow—germ cell cancer	0.00536	0.0125	CbGeAlD
Orlistat—PLA2G7—spinal cord—germ cell cancer	0.00533	0.0125	CbGeAlD
Orlistat—FASN—decidua—germ cell cancer	0.00532	0.0124	CbGeAlD
Orlistat—ABHD12—medulla oblongata—germ cell cancer	0.00526	0.0123	CbGeAlD
Orlistat—DAGLB—cerebellum—germ cell cancer	0.00524	0.0122	CbGeAlD
Orlistat—PLA2G7—female gonad—germ cell cancer	0.00516	0.0121	CbGeAlD
Orlistat—ABHD16A—midbrain—germ cell cancer	0.00513	0.012	CbGeAlD
Orlistat—ABHD16A—bone marrow—germ cell cancer	0.00503	0.0117	CbGeAlD
Orlistat—ABHD16A—spinal cord—germ cell cancer	0.00501	0.0117	CbGeAlD
Orlistat—FASN—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A3—germ cell cancer	0.00488	0.0319	CbGpPWpGaD
Orlistat—ABHD12—adrenal gland—germ cell cancer	0.00487	0.0114	CbGeAlD
Orlistat—ABHD16A—female gonad—germ cell cancer	0.00485	0.0113	CbGeAlD
Orlistat—ABHD12—midbrain—germ cell cancer	0.00481	0.0112	CbGeAlD
Orlistat—PLA2G7—endocrine gland—germ cell cancer	0.0048	0.0112	CbGeAlD
Orlistat—ABHD12—spinal cord—germ cell cancer	0.00469	0.011	CbGeAlD
Orlistat—FASN—uterus—germ cell cancer	0.00466	0.0109	CbGeAlD
Orlistat—FASN—pituitary gland—germ cell cancer	0.00457	0.0107	CbGeAlD
Orlistat—PNLIP—female gonad—germ cell cancer	0.00454	0.0106	CbGeAlD
Orlistat—ABHD12—female gonad—germ cell cancer	0.00454	0.0106	CbGeAlD
Orlistat—FASN—medulla oblongata—germ cell cancer	0.00441	0.0103	CbGeAlD
Orlistat—ABHD16A—testis—germ cell cancer	0.0043	0.01	CbGeAlD
Orlistat—DAGLB—brain—germ cell cancer	0.00425	0.00993	CbGeAlD
Orlistat—PNLIP—endocrine gland—germ cell cancer	0.00422	0.00986	CbGeAlD
Orlistat—PNLIP—head—germ cell cancer	0.00417	0.00974	CbGeAlD
Orlistat—DAGLB—lymph node—germ cell cancer	0.00411	0.0096	CbGeAlD
Orlistat—FASN—adrenal gland—germ cell cancer	0.00409	0.00954	CbGeAlD
Orlistat—FASN—midbrain—germ cell cancer	0.00403	0.00942	CbGeAlD
Orlistat—ABHD12—testis—germ cell cancer	0.00403	0.0094	CbGeAlD
Orlistat—ABHD16A—cerebellum—germ cell cancer	0.00397	0.00927	CbGeAlD
Orlistat—FASN—spinal cord—germ cell cancer	0.00394	0.00919	CbGeAlD
Orlistat—DAGLB—Platelet activation, signaling and aggregation—CD9—germ cell cancer	0.00384	0.025	CbGpPWpGaD
Orlistat—DAGLA—Platelet activation, signaling and aggregation—CD9—germ cell cancer	0.00384	0.025	CbGpPWpGaD
Orlistat—FASN—female gonad—germ cell cancer	0.00381	0.0089	CbGeAlD
Orlistat—ABHD12—cerebellum—germ cell cancer	0.00372	0.00869	CbGeAlD
Orlistat—PLA2G4A—trigeminal ganglion—germ cell cancer	0.00344	0.00803	CbGeAlD
Orlistat—PLA2G7—brain—germ cell cancer	0.00344	0.00802	CbGeAlD
Orlistat—CYP3A4—urine—germ cell cancer	0.00339	0.00791	CbGeAlD
Orlistat—FASN—testis—germ cell cancer	0.00338	0.00789	CbGeAlD
Orlistat—PLA2G7—lymph node—germ cell cancer	0.00332	0.00775	CbGeAlD
Orlistat—FASN—cerebellum—germ cell cancer	0.00312	0.00729	CbGeAlD
Orlistat—ABHD16A—lymph node—germ cell cancer	0.00311	0.00727	CbGeAlD
Orlistat—DAGLA—G alpha (q) signalling events—OXT—germ cell cancer	0.00304	0.0198	CbGpPWpGaD
Orlistat—DAGLB—G alpha (q) signalling events—OXT—germ cell cancer	0.00304	0.0198	CbGpPWpGaD
Orlistat—ABHD12—brain—germ cell cancer	0.00302	0.00705	CbGeAlD
Orlistat—ABHD12—lymph node—germ cell cancer	0.00292	0.00682	CbGeAlD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	0.00272	0.0177	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	0.00272	0.0177	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—INHA—germ cell cancer	0.00263	0.0172	CbGpPWpGaD
Orlistat—PLA2G4A—decidua—germ cell cancer	0.00256	0.00598	CbGeAlD
Orlistat—FASN—brain—germ cell cancer	0.00254	0.00592	CbGeAlD
Orlistat—FASN—lymph node—germ cell cancer	0.00245	0.00572	CbGeAlD
Orlistat—PLA2G7—Metabolism of proteins—KLF4—germ cell cancer	0.00235	0.0153	CbGpPWpGaD
Orlistat—PLA2G4A—pituitary gland—germ cell cancer	0.0022	0.00514	CbGeAlD
Orlistat—FASN—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	0.00219	0.0143	CbGpPWpGaD
Orlistat—PLA2G4A—medulla oblongata—germ cell cancer	0.00212	0.00496	CbGeAlD
Orlistat—DAGLA—G alpha (q) signalling events—AVP—germ cell cancer	0.00208	0.0136	CbGpPWpGaD
Orlistat—DAGLB—G alpha (q) signalling events—AVP—germ cell cancer	0.00208	0.0136	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—ALPL—germ cell cancer	0.00198	0.0129	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—CD9—germ cell cancer	0.00198	0.0129	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—CD9—germ cell cancer	0.00198	0.0129	CbGpPWpGaD
Orlistat—PLA2G4A—adrenal gland—germ cell cancer	0.00196	0.00459	CbGeAlD
Orlistat—PLA2G4A—midbrain—germ cell cancer	0.00194	0.00453	CbGeAlD
Orlistat—PLA2G4A—bone marrow—germ cell cancer	0.0019	0.00444	CbGeAlD
Orlistat—PLA2G4A—spinal cord—germ cell cancer	0.00189	0.00442	CbGeAlD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	0.00186	0.0122	CbGpPWpGaD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	0.00186	0.0122	CbGpPWpGaD
Orlistat—PLA2G4A—female gonad—germ cell cancer	0.00183	0.00428	CbGeAlD
Orlistat—PLA2G4A—endocrine gland—germ cell cancer	0.0017	0.00398	CbGeAlD
Orlistat—PLA2G4A—testis—germ cell cancer	0.00162	0.00379	CbGeAlD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.00123	0.00805	CbGpPWpGaD
Orlistat—PLA2G4A—brain—germ cell cancer	0.00122	0.00285	CbGeAlD
Orlistat—Vaginal inflammation—Methotrexate—germ cell cancer	0.00121	0.00297	CcSEcCtD
Orlistat—Neuropathy peripheral—Cisplatin—germ cell cancer	0.00121	0.00297	CcSEcCtD
Orlistat—Malaise—Bleomycin—germ cell cancer	0.00118	0.0029	CcSEcCtD
Orlistat—PLA2G4A—lymph node—germ cell cancer	0.00118	0.00275	CbGeAlD
Orlistat—Hepatobiliary disease—Cisplatin—germ cell cancer	0.00116	0.00286	CcSEcCtD
Orlistat—Immune system disorder—Ifosfamide—germ cell cancer	0.00116	0.00285	CcSEcCtD
Orlistat—Mediastinal disorder—Ifosfamide—germ cell cancer	0.00116	0.00284	CcSEcCtD
Orlistat—Vaginal infection—Methotrexate—germ cell cancer	0.00114	0.0028	CcSEcCtD
Orlistat—Cough—Bleomycin—germ cell cancer	0.00114	0.0028	CcSEcCtD
Orlistat—Paraesthesia—Vinblastine—germ cell cancer	0.00113	0.00279	CcSEcCtD
Orlistat—Alopecia—Ifosfamide—germ cell cancer	0.00113	0.00279	CcSEcCtD
Orlistat—Ill-defined disorder—Dactinomycin—germ cell cancer	0.00113	0.00278	CcSEcCtD
Orlistat—Infestation—Etoposide—germ cell cancer	0.00113	0.00277	CcSEcCtD
Orlistat—Infestation NOS—Etoposide—germ cell cancer	0.00113	0.00277	CcSEcCtD
Orlistat—Mental disorder—Ifosfamide—germ cell cancer	0.00112	0.00276	CcSEcCtD
Orlistat—Malnutrition—Ifosfamide—germ cell cancer	0.00112	0.00274	CcSEcCtD
Orlistat—Chest pain—Bleomycin—germ cell cancer	0.00111	0.00273	CcSEcCtD
Orlistat—Myalgia—Bleomycin—germ cell cancer	0.00111	0.00273	CcSEcCtD
Orlistat—Renal failure—Etoposide—germ cell cancer	0.00111	0.00273	CcSEcCtD
Orlistat—Neuropathy peripheral—Etoposide—germ cell cancer	0.00111	0.00272	CcSEcCtD
Orlistat—Discomfort—Bleomycin—germ cell cancer	0.0011	0.0027	CcSEcCtD
Orlistat—Malaise—Dactinomycin—germ cell cancer	0.0011	0.0027	CcSEcCtD
Orlistat—Decreased appetite—Vinblastine—germ cell cancer	0.0011	0.0027	CcSEcCtD
Orlistat—Urine output increased—Methotrexate—germ cell cancer	0.00109	0.00268	CcSEcCtD
Orlistat—Neoplasm—Methotrexate—germ cell cancer	0.00109	0.00268	CcSEcCtD
Orlistat—Urinary tract disorder—Cisplatin—germ cell cancer	0.00109	0.00268	CcSEcCtD
Orlistat—Urethral disorder—Cisplatin—germ cell cancer	0.00108	0.00266	CcSEcCtD
Orlistat—Pain—Vinblastine—germ cell cancer	0.00108	0.00265	CcSEcCtD
Orlistat—Hepatobiliary disease—Etoposide—germ cell cancer	0.00107	0.00262	CcSEcCtD
Orlistat—Oedema—Bleomycin—germ cell cancer	0.00107	0.00262	CcSEcCtD
Orlistat—Anaphylactic shock—Bleomycin—germ cell cancer	0.00107	0.00262	CcSEcCtD
Orlistat—Infection—Bleomycin—germ cell cancer	0.00106	0.0026	CcSEcCtD
Orlistat—Vision blurred—Ifosfamide—germ cell cancer	0.00105	0.00259	CcSEcCtD
Orlistat—Feeling abnormal—Vinblastine—germ cell cancer	0.00104	0.00256	CcSEcCtD
Orlistat—Myalgia—Dactinomycin—germ cell cancer	0.00104	0.00255	CcSEcCtD
Orlistat—Ill-defined disorder—Ifosfamide—germ cell cancer	0.00104	0.00255	CcSEcCtD
Orlistat—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	0.00103	0.00674	CbGpPWpGaD
Orlistat—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00103	0.00254	CcSEcCtD
Orlistat—Discomfort—Dactinomycin—germ cell cancer	0.00102	0.00252	CcSEcCtD
Orlistat—Angioedema—Ifosfamide—germ cell cancer	0.00102	0.00251	CcSEcCtD
Orlistat—Diabetes mellitus—Methotrexate—germ cell cancer	0.00101	0.00248	CcSEcCtD
Orlistat—Malaise—Ifosfamide—germ cell cancer	0.00101	0.00247	CcSEcCtD
Orlistat—Vertigo—Ifosfamide—germ cell cancer	0.001	0.00247	CcSEcCtD
Orlistat—Urinary tract disorder—Etoposide—germ cell cancer	0.001	0.00246	CcSEcCtD
Orlistat—Polyuria—Methotrexate—germ cell cancer	0.000998	0.00245	CcSEcCtD
Orlistat—Immune system disorder—Cisplatin—germ cell cancer	0.000998	0.00245	CcSEcCtD
Orlistat—Abdominal pain—Vinblastine—germ cell cancer	0.000998	0.00245	CcSEcCtD
Orlistat—Mediastinal disorder—Cisplatin—germ cell cancer	0.000996	0.00245	CcSEcCtD
Orlistat—Oedema—Dactinomycin—germ cell cancer	0.000994	0.00244	CcSEcCtD
Orlistat—Urethral disorder—Etoposide—germ cell cancer	0.000993	0.00244	CcSEcCtD
Orlistat—Infection—Dactinomycin—germ cell cancer	0.000987	0.00243	CcSEcCtD
Orlistat—Palpitations—Ifosfamide—germ cell cancer	0.000986	0.00242	CcSEcCtD
Orlistat—Alopecia—Cisplatin—germ cell cancer	0.000977	0.0024	CcSEcCtD
Orlistat—Hepatic failure—Methotrexate—germ cell cancer	0.000976	0.0024	CcSEcCtD
Orlistat—Cough—Ifosfamide—germ cell cancer	0.000974	0.00239	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000971	0.00239	CcSEcCtD
Orlistat—Convulsion—Ifosfamide—germ cell cancer	0.000967	0.00238	CcSEcCtD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—CD9—germ cell cancer	0.000965	0.0063	CbGpPWpGaD
Orlistat—Malnutrition—Cisplatin—germ cell cancer	0.000962	0.00237	CcSEcCtD
Orlistat—Paraesthesia—Bleomycin—germ cell cancer	0.000957	0.00235	CcSEcCtD
Orlistat—Chest pain—Ifosfamide—germ cell cancer	0.00095	0.00234	CcSEcCtD
Orlistat—Myalgia—Ifosfamide—germ cell cancer	0.00095	0.00234	CcSEcCtD
Orlistat—Flatulence—Cisplatin—germ cell cancer	0.000948	0.00233	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000944	0.00232	CcSEcCtD
Orlistat—Discomfort—Ifosfamide—germ cell cancer	0.000939	0.00231	CcSEcCtD
Orlistat—FASN—p73 transcription factor network—MYC—germ cell cancer	0.000934	0.0061	CbGpPWpGaD
Orlistat—Hypersensitivity—Vinblastine—germ cell cancer	0.00093	0.00229	CcSEcCtD
Orlistat—Decreased appetite—Bleomycin—germ cell cancer	0.000926	0.00228	CcSEcCtD
Orlistat—Muscle spasms—Cisplatin—germ cell cancer	0.000925	0.00227	CcSEcCtD
Orlistat—Immune system disorder—Etoposide—germ cell cancer	0.000915	0.00225	CcSEcCtD
Orlistat—Mediastinal disorder—Etoposide—germ cell cancer	0.000913	0.00224	CcSEcCtD
Orlistat—Pain—Bleomycin—germ cell cancer	0.000911	0.00224	CcSEcCtD
Orlistat—Oedema—Ifosfamide—germ cell cancer	0.000911	0.00224	CcSEcCtD
Orlistat—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000911	0.00224	CcSEcCtD
Orlistat—Vision blurred—Cisplatin—germ cell cancer	0.000907	0.00223	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000906	0.00223	CcSEcCtD
Orlistat—Asthenia—Vinblastine—germ cell cancer	0.000905	0.00223	CcSEcCtD
Orlistat—Infection—Ifosfamide—germ cell cancer	0.000905	0.00222	CcSEcCtD
Orlistat—Alopecia—Etoposide—germ cell cancer	0.000895	0.0022	CcSEcCtD
Orlistat—Nervous system disorder—Ifosfamide—germ cell cancer	0.000893	0.0022	CcSEcCtD
Orlistat—Ill-defined disorder—Cisplatin—germ cell cancer	0.000893	0.00219	CcSEcCtD
Orlistat—Skin disorder—Ifosfamide—germ cell cancer	0.000885	0.00217	CcSEcCtD
Orlistat—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000881	0.00216	CcSEcCtD
Orlistat—Feeling abnormal—Bleomycin—germ cell cancer	0.000878	0.00216	CcSEcCtD
Orlistat—Osteoarthritis—Methotrexate—germ cell cancer	0.000877	0.00216	CcSEcCtD
Orlistat—FASN—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000873	0.00569	CbGpPWpGaD
Orlistat—Malaise—Cisplatin—germ cell cancer	0.000868	0.00213	CcSEcCtD
Orlistat—DAGLB—GPCR downstream signaling—OXT—germ cell cancer	0.000866	0.00565	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—OXT—germ cell cancer	0.000866	0.00565	CbGpPWpGaD
Orlistat—Decreased appetite—Dactinomycin—germ cell cancer	0.000864	0.00212	CcSEcCtD
Orlistat—Diarrhoea—Vinblastine—germ cell cancer	0.000863	0.00212	CcSEcCtD
Orlistat—Dysgeusia—Etoposide—germ cell cancer	0.000863	0.00212	CcSEcCtD
Orlistat—Fatigue—Dactinomycin—germ cell cancer	0.000857	0.00211	CcSEcCtD
Orlistat—FASN—AMPK Signaling—TP53—germ cell cancer	0.000855	0.00558	CbGpPWpGaD
Orlistat—Back pain—Etoposide—germ cell cancer	0.000853	0.0021	CcSEcCtD
Orlistat—Pain—Dactinomycin—germ cell cancer	0.00085	0.00209	CcSEcCtD
Orlistat—Muscle spasms—Etoposide—germ cell cancer	0.000847	0.00208	CcSEcCtD
Orlistat—Urticaria—Bleomycin—germ cell cancer	0.000847	0.00208	CcSEcCtD
Orlistat—Body temperature increased—Bleomycin—germ cell cancer	0.000842	0.00207	CcSEcCtD
Orlistat—Dizziness—Vinblastine—germ cell cancer	0.000834	0.00205	CcSEcCtD
Orlistat—Convulsion—Cisplatin—germ cell cancer	0.000834	0.00205	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00083	0.00204	CcSEcCtD
Orlistat—Myalgia—Cisplatin—germ cell cancer	0.000819	0.00201	CcSEcCtD
Orlistat—Feeling abnormal—Dactinomycin—germ cell cancer	0.000819	0.00201	CcSEcCtD
Orlistat—Paraesthesia—Ifosfamide—germ cell cancer	0.000818	0.00201	CcSEcCtD
Orlistat—Ill-defined disorder—Etoposide—germ cell cancer	0.000818	0.00201	CcSEcCtD
Orlistat—PNLIP—Disease—SLC2A3—germ cell cancer	0.000817	0.00533	CbGpPWpGaD
Orlistat—Anxiety—Cisplatin—germ cell cancer	0.000816	0.00201	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000813	0.002	CcSEcCtD
Orlistat—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000813	0.002	CcSEcCtD
Orlistat—Discomfort—Cisplatin—germ cell cancer	0.000809	0.00199	CcSEcCtD
Orlistat—Vomiting—Vinblastine—germ cell cancer	0.000802	0.00197	CcSEcCtD
Orlistat—Malaise—Etoposide—germ cell cancer	0.000795	0.00195	CcSEcCtD
Orlistat—Breast disorder—Methotrexate—germ cell cancer	0.000792	0.00195	CcSEcCtD
Orlistat—Vertigo—Etoposide—germ cell cancer	0.000792	0.00195	CcSEcCtD
Orlistat—Decreased appetite—Ifosfamide—germ cell cancer	0.000792	0.00195	CcSEcCtD
Orlistat—Headache—Vinblastine—germ cell cancer	0.000791	0.00194	CcSEcCtD
Orlistat—PLA2G4A—p38 MAPK Signaling Pathway—MYC—germ cell cancer	0.000787	0.00514	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—OXT—germ cell cancer	0.000786	0.00513	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—OXT—germ cell cancer	0.000786	0.00513	CbGpPWpGaD
Orlistat—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000786	0.00193	CcSEcCtD
Orlistat—Abdominal pain—Dactinomycin—germ cell cancer	0.000786	0.00193	CcSEcCtD
Orlistat—Body temperature increased—Dactinomycin—germ cell cancer	0.000786	0.00193	CcSEcCtD
Orlistat—Fatigue—Ifosfamide—germ cell cancer	0.000785	0.00193	CcSEcCtD
Orlistat—Oedema—Cisplatin—germ cell cancer	0.000785	0.00193	CcSEcCtD
Orlistat—Anaphylactic shock—Cisplatin—germ cell cancer	0.000785	0.00193	CcSEcCtD
Orlistat—Hypersensitivity—Bleomycin—germ cell cancer	0.000785	0.00193	CcSEcCtD
Orlistat—Infection—Cisplatin—germ cell cancer	0.00078	0.00192	CcSEcCtD
Orlistat—Pain—Ifosfamide—germ cell cancer	0.000779	0.00191	CcSEcCtD
Orlistat—Nervous system disorder—Cisplatin—germ cell cancer	0.00077	0.00189	CcSEcCtD
Orlistat—Cough—Etoposide—germ cell cancer	0.000769	0.00189	CcSEcCtD
Orlistat—Asthenia—Bleomycin—germ cell cancer	0.000765	0.00188	CcSEcCtD
Orlistat—Convulsion—Etoposide—germ cell cancer	0.000764	0.00188	CcSEcCtD
Orlistat—Skin disorder—Cisplatin—germ cell cancer	0.000763	0.00188	CcSEcCtD
Orlistat—Hyperhidrosis—Cisplatin—germ cell cancer	0.000759	0.00187	CcSEcCtD
Orlistat—Asthma—Methotrexate—germ cell cancer	0.000758	0.00186	CcSEcCtD
Orlistat—Pruritus—Bleomycin—germ cell cancer	0.000754	0.00185	CcSEcCtD
Orlistat—Feeling abnormal—Ifosfamide—germ cell cancer	0.000751	0.00185	CcSEcCtD
Orlistat—Chest pain—Etoposide—germ cell cancer	0.00075	0.00184	CcSEcCtD
Orlistat—Nausea—Vinblastine—germ cell cancer	0.00075	0.00184	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000745	0.00183	CcSEcCtD
Orlistat—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000745	0.00183	CcSEcCtD
Orlistat—Pancreatitis—Methotrexate—germ cell cancer	0.000743	0.00183	CcSEcCtD
Orlistat—Discomfort—Etoposide—germ cell cancer	0.000741	0.00182	CcSEcCtD
Orlistat—Hypersensitivity—Dactinomycin—germ cell cancer	0.000732	0.0018	CcSEcCtD
Orlistat—Abdominal discomfort—Methotrexate—germ cell cancer	0.000726	0.00179	CcSEcCtD
Orlistat—Urticaria—Ifosfamide—germ cell cancer	0.000724	0.00178	CcSEcCtD
Orlistat—Body temperature increased—Ifosfamide—germ cell cancer	0.00072	0.00177	CcSEcCtD
Orlistat—Abdominal pain—Ifosfamide—germ cell cancer	0.00072	0.00177	CcSEcCtD
Orlistat—Anaphylactic shock—Etoposide—germ cell cancer	0.000719	0.00177	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000715	0.00176	CcSEcCtD
Orlistat—Infection—Etoposide—germ cell cancer	0.000715	0.00176	CcSEcCtD
Orlistat—Asthenia—Dactinomycin—germ cell cancer	0.000713	0.00175	CcSEcCtD
Orlistat—Paraesthesia—Cisplatin—germ cell cancer	0.000705	0.00173	CcSEcCtD
Orlistat—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000704	0.00173	CcSEcCtD
Orlistat—Skin disorder—Etoposide—germ cell cancer	0.000699	0.00172	CcSEcCtD
Orlistat—Hyperhidrosis—Etoposide—germ cell cancer	0.000695	0.00171	CcSEcCtD
Orlistat—PNLIP—Metabolism—SLC2A3—germ cell cancer	0.000684	0.00446	CbGpPWpGaD
Orlistat—Decreased appetite—Cisplatin—germ cell cancer	0.000683	0.00168	CcSEcCtD
Orlistat—Diarrhoea—Dactinomycin—germ cell cancer	0.00068	0.00167	CcSEcCtD
Orlistat—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000678	0.00167	CcSEcCtD
Orlistat—Vomiting—Bleomycin—germ cell cancer	0.000678	0.00167	CcSEcCtD
Orlistat—Infestation NOS—Methotrexate—germ cell cancer	0.000676	0.00166	CcSEcCtD
Orlistat—Infestation—Methotrexate—germ cell cancer	0.000676	0.00166	CcSEcCtD
Orlistat—PNLIP—Metabolism—SLC22A3—germ cell cancer	0.000674	0.0044	CbGpPWpGaD
Orlistat—Depression—Methotrexate—germ cell cancer	0.000674	0.00166	CcSEcCtD
Orlistat—Rash—Bleomycin—germ cell cancer	0.000672	0.00165	CcSEcCtD
Orlistat—Pain—Cisplatin—germ cell cancer	0.000671	0.00165	CcSEcCtD
Orlistat—Dermatitis—Bleomycin—germ cell cancer	0.000671	0.00165	CcSEcCtD
Orlistat—Hypersensitivity—Ifosfamide—germ cell cancer	0.000671	0.00165	CcSEcCtD
Orlistat—Renal failure—Methotrexate—germ cell cancer	0.000664	0.00163	CcSEcCtD
Orlistat—Asthenia—Ifosfamide—germ cell cancer	0.000653	0.00161	CcSEcCtD
Orlistat—Feeling abnormal—Cisplatin—germ cell cancer	0.000647	0.00159	CcSEcCtD
Orlistat—Paraesthesia—Etoposide—germ cell cancer	0.000646	0.00159	CcSEcCtD
Orlistat—Pruritus—Ifosfamide—germ cell cancer	0.000644	0.00158	CcSEcCtD
Orlistat—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000639	0.00157	CcSEcCtD
Orlistat—Nausea—Bleomycin—germ cell cancer	0.000633	0.00156	CcSEcCtD
Orlistat—Vomiting—Dactinomycin—germ cell cancer	0.000632	0.00155	CcSEcCtD
Orlistat—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—germ cell cancer	0.000632	0.00412	CbGpPWpGaD
Orlistat—Rash—Dactinomycin—germ cell cancer	0.000627	0.00154	CcSEcCtD
Orlistat—Decreased appetite—Etoposide—germ cell cancer	0.000625	0.00154	CcSEcCtD
Orlistat—Diarrhoea—Ifosfamide—germ cell cancer	0.000623	0.00153	CcSEcCtD
Orlistat—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000621	0.00153	CcSEcCtD
Orlistat—Body temperature increased—Cisplatin—germ cell cancer	0.000621	0.00153	CcSEcCtD
Orlistat—Fatigue—Etoposide—germ cell cancer	0.00062	0.00152	CcSEcCtD
Orlistat—PLA2G4A—p38 MAPK Signaling Pathway—HRAS—germ cell cancer	0.000618	0.00403	CbGpPWpGaD
Orlistat—Pain—Etoposide—germ cell cancer	0.000615	0.00151	CcSEcCtD
Orlistat—Haemoglobin—Methotrexate—germ cell cancer	0.00061	0.0015	CcSEcCtD
Orlistat—Hepatitis—Methotrexate—germ cell cancer	0.000607	0.00149	CcSEcCtD
Orlistat—Haemorrhage—Methotrexate—germ cell cancer	0.000607	0.00149	CcSEcCtD
Orlistat—Dizziness—Ifosfamide—germ cell cancer	0.000602	0.00148	CcSEcCtD
Orlistat—Pharyngitis—Methotrexate—germ cell cancer	0.000602	0.00148	CcSEcCtD
Orlistat—Urinary tract disorder—Methotrexate—germ cell cancer	0.000599	0.00147	CcSEcCtD
Orlistat—Urethral disorder—Methotrexate—germ cell cancer	0.000595	0.00146	CcSEcCtD
Orlistat—DAGLA—GPCR downstream signaling—AVP—germ cell cancer	0.000594	0.00387	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—AVP—germ cell cancer	0.000594	0.00387	CbGpPWpGaD
Orlistat—Feeling abnormal—Etoposide—germ cell cancer	0.000593	0.00146	CcSEcCtD
Orlistat—Nausea—Dactinomycin—germ cell cancer	0.00059	0.00145	CcSEcCtD
Orlistat—Gastrointestinal pain—Etoposide—germ cell cancer	0.000588	0.00145	CcSEcCtD
Orlistat—Vomiting—Ifosfamide—germ cell cancer	0.000579	0.00142	CcSEcCtD
Orlistat—Hypersensitivity—Cisplatin—germ cell cancer	0.000579	0.00142	CcSEcCtD
Orlistat—FASN—Disease—SLC2A3—germ cell cancer	0.000578	0.00377	CbGpPWpGaD
Orlistat—Rash—Ifosfamide—germ cell cancer	0.000574	0.00141	CcSEcCtD
Orlistat—Dermatitis—Ifosfamide—germ cell cancer	0.000574	0.00141	CcSEcCtD
Orlistat—Urticaria—Etoposide—germ cell cancer	0.000571	0.0014	CcSEcCtD
Orlistat—Body temperature increased—Etoposide—germ cell cancer	0.000569	0.0014	CcSEcCtD
Orlistat—Abdominal pain—Etoposide—germ cell cancer	0.000569	0.0014	CcSEcCtD
Orlistat—Asthenia—Cisplatin—germ cell cancer	0.000563	0.00139	CcSEcCtD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	0.000562	0.00367	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	0.000562	0.00367	CbGpPWpGaD
Orlistat—CYP3A4—endocrine gland—germ cell cancer	0.000562	0.00131	CbGeAlD
Orlistat—PLA2G4A—PDGF Pathway—HRAS—germ cell cancer	0.000554	0.00361	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—CRABP1—germ cell cancer	0.000549	0.00358	CbGpPWpGaD
Orlistat—Immune system disorder—Methotrexate—germ cell cancer	0.000548	0.00135	CcSEcCtD
Orlistat—Mediastinal disorder—Methotrexate—germ cell cancer	0.000547	0.00134	CcSEcCtD
Orlistat—Nausea—Ifosfamide—germ cell cancer	0.000541	0.00133	CcSEcCtD
Orlistat—DAGLB—Signaling by GPCR—AVP—germ cell cancer	0.000539	0.00352	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—AVP—germ cell cancer	0.000539	0.00352	CbGpPWpGaD
Orlistat—Diarrhoea—Cisplatin—germ cell cancer	0.000537	0.00132	CcSEcCtD
Orlistat—Alopecia—Methotrexate—germ cell cancer	0.000536	0.00132	CcSEcCtD
Orlistat—Mental disorder—Methotrexate—germ cell cancer	0.000531	0.00131	CcSEcCtD
Orlistat—Hypersensitivity—Etoposide—germ cell cancer	0.00053	0.0013	CcSEcCtD
Orlistat—Malnutrition—Methotrexate—germ cell cancer	0.000528	0.0013	CcSEcCtD
Orlistat—Dysgeusia—Methotrexate—germ cell cancer	0.000517	0.00127	CcSEcCtD
Orlistat—Asthenia—Etoposide—germ cell cancer	0.000516	0.00127	CcSEcCtD
Orlistat—Back pain—Methotrexate—germ cell cancer	0.000511	0.00126	CcSEcCtD
Orlistat—Pruritus—Etoposide—germ cell cancer	0.000509	0.00125	CcSEcCtD
Orlistat—Vomiting—Cisplatin—germ cell cancer	0.000499	0.00123	CcSEcCtD
Orlistat—Vision blurred—Methotrexate—germ cell cancer	0.000498	0.00122	CcSEcCtD
Orlistat—PLA2G4A—Hemostasis—CD9—germ cell cancer	0.000497	0.00325	CbGpPWpGaD
Orlistat—Rash—Cisplatin—germ cell cancer	0.000495	0.00122	CcSEcCtD
Orlistat—Dermatitis—Cisplatin—germ cell cancer	0.000495	0.00122	CcSEcCtD
Orlistat—Diarrhoea—Etoposide—germ cell cancer	0.000492	0.00121	CcSEcCtD
Orlistat—Ill-defined disorder—Methotrexate—germ cell cancer	0.00049	0.0012	CcSEcCtD
Orlistat—FASN—Metabolism—SLC2A3—germ cell cancer	0.000484	0.00316	CbGpPWpGaD
Orlistat—FASN—Metabolism—SLC22A3—germ cell cancer	0.000477	0.00311	CbGpPWpGaD
Orlistat—Malaise—Methotrexate—germ cell cancer	0.000476	0.00117	CcSEcCtD
Orlistat—Dizziness—Etoposide—germ cell cancer	0.000476	0.00117	CcSEcCtD
Orlistat—Vertigo—Methotrexate—germ cell cancer	0.000474	0.00117	CcSEcCtD
Orlistat—PNLIP—Disease—FGF4—germ cell cancer	0.000469	0.00306	CbGpPWpGaD
Orlistat—Nausea—Cisplatin—germ cell cancer	0.000466	0.00115	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—OXT—germ cell cancer	0.000465	0.00303	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—OXT—germ cell cancer	0.000465	0.00303	CbGpPWpGaD
Orlistat—Cough—Methotrexate—germ cell cancer	0.000461	0.00113	CcSEcCtD
Orlistat—Convulsion—Methotrexate—germ cell cancer	0.000457	0.00112	CcSEcCtD
Orlistat—Vomiting—Etoposide—germ cell cancer	0.000457	0.00112	CcSEcCtD
Orlistat—Rash—Etoposide—germ cell cancer	0.000454	0.00112	CcSEcCtD
Orlistat—Dermatitis—Etoposide—germ cell cancer	0.000453	0.00111	CcSEcCtD
Orlistat—Headache—Etoposide—germ cell cancer	0.000451	0.00111	CcSEcCtD
Orlistat—Myalgia—Methotrexate—germ cell cancer	0.000449	0.00111	CcSEcCtD
Orlistat—Chest pain—Methotrexate—germ cell cancer	0.000449	0.00111	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000446	0.0011	CcSEcCtD
Orlistat—Discomfort—Methotrexate—germ cell cancer	0.000444	0.00109	CcSEcCtD
Orlistat—Anaphylactic shock—Methotrexate—germ cell cancer	0.000431	0.00106	CcSEcCtD
Orlistat—Infection—Methotrexate—germ cell cancer	0.000428	0.00105	CcSEcCtD
Orlistat—Nausea—Etoposide—germ cell cancer	0.000427	0.00105	CcSEcCtD
Orlistat—Nervous system disorder—Methotrexate—germ cell cancer	0.000423	0.00104	CcSEcCtD
Orlistat—PNLIP—Disease—H2AFZ—germ cell cancer	0.000419	0.00273	CbGpPWpGaD
Orlistat—Skin disorder—Methotrexate—germ cell cancer	0.000419	0.00103	CcSEcCtD
Orlistat—Hyperhidrosis—Methotrexate—germ cell cancer	0.000417	0.00102	CcSEcCtD
Orlistat—DAGLB—Signaling Pathways—FGF4—germ cell cancer	0.000397	0.00259	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—FGF4—germ cell cancer	0.000397	0.00259	CbGpPWpGaD
Orlistat—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000393	0.000965	CcSEcCtD
Orlistat—Insomnia—Methotrexate—germ cell cancer	0.00039	0.000958	CcSEcCtD
Orlistat—FASN—Metabolism—CRABP1—germ cell cancer	0.000389	0.00254	CbGpPWpGaD
Orlistat—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—HRAS—germ cell cancer	0.000387	0.00253	CbGpPWpGaD
Orlistat—Paraesthesia—Methotrexate—germ cell cancer	0.000387	0.000951	CcSEcCtD
Orlistat—PNLIP—Disease—KITLG—germ cell cancer	0.000385	0.00252	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—OXT—germ cell cancer	0.000385	0.00251	CbGpPWpGaD
Orlistat—Dyspepsia—Methotrexate—germ cell cancer	0.000379	0.000932	CcSEcCtD
Orlistat—PLA2G4A—Endothelins—HRAS—germ cell cancer	0.000377	0.00246	CbGpPWpGaD
Orlistat—Decreased appetite—Methotrexate—germ cell cancer	0.000375	0.000921	CcSEcCtD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000375	0.00244	CbGpPWpGaD
Orlistat—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000372	0.000915	CcSEcCtD
Orlistat—Fatigue—Methotrexate—germ cell cancer	0.000371	0.000913	CcSEcCtD
Orlistat—Pain—Methotrexate—germ cell cancer	0.000368	0.000906	CcSEcCtD
Orlistat—Feeling abnormal—Methotrexate—germ cell cancer	0.000355	0.000873	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—H2AFZ—germ cell cancer	0.000354	0.00231	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—H2AFZ—germ cell cancer	0.000354	0.00231	CbGpPWpGaD
Orlistat—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000352	0.000866	CcSEcCtD
Orlistat—Urticaria—Methotrexate—germ cell cancer	0.000342	0.000842	CcSEcCtD
Orlistat—Body temperature increased—Methotrexate—germ cell cancer	0.000341	0.000837	CcSEcCtD
Orlistat—Abdominal pain—Methotrexate—germ cell cancer	0.000341	0.000837	CcSEcCtD
Orlistat—FASN—Disease—FGF4—germ cell cancer	0.000332	0.00217	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—FGF4—germ cell cancer	0.000329	0.00214	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—KITLG—germ cell cancer	0.000326	0.00213	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—KITLG—germ cell cancer	0.000326	0.00213	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—AVP—germ cell cancer	0.000318	0.00208	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—AVP—germ cell cancer	0.000318	0.00208	CbGpPWpGaD
Orlistat—Hypersensitivity—Methotrexate—germ cell cancer	0.000317	0.00078	CcSEcCtD
Orlistat—Asthenia—Methotrexate—germ cell cancer	0.000309	0.00076	CcSEcCtD
Orlistat—Pruritus—Methotrexate—germ cell cancer	0.000305	0.000749	CcSEcCtD
Orlistat—FASN—Disease—H2AFZ—germ cell cancer	0.000296	0.00193	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—TP53—germ cell cancer	0.000296	0.00193	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—TP53—germ cell cancer	0.000296	0.00193	CbGpPWpGaD
Orlistat—Diarrhoea—Methotrexate—germ cell cancer	0.000295	0.000725	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—H2AFZ—germ cell cancer	0.000293	0.00191	CbGpPWpGaD
Orlistat—PNLIP—Disease—FGFR3—germ cell cancer	0.000287	0.00187	CbGpPWpGaD
Orlistat—Dizziness—Methotrexate—germ cell cancer	0.000285	0.000701	CcSEcCtD
Orlistat—DAGLB—Hemostasis—HRAS—germ cell cancer	0.000283	0.00185	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—HRAS—germ cell cancer	0.000283	0.00185	CbGpPWpGaD
Orlistat—PLA2G4A—PDGFR-beta signaling pathway—MYC—germ cell cancer	0.000278	0.00181	CbGpPWpGaD
Orlistat—Vomiting—Methotrexate—germ cell cancer	0.000274	0.000674	CcSEcCtD
Orlistat—FASN—Disease—KITLG—germ cell cancer	0.000273	0.00178	CbGpPWpGaD
Orlistat—Rash—Methotrexate—germ cell cancer	0.000272	0.000668	CcSEcCtD
Orlistat—Dermatitis—Methotrexate—germ cell cancer	0.000271	0.000667	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—KITLG—germ cell cancer	0.00027	0.00176	CbGpPWpGaD
Orlistat—Headache—Methotrexate—germ cell cancer	0.00027	0.000664	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—AVP—germ cell cancer	0.000264	0.00172	CbGpPWpGaD
Orlistat—PNLIP—Disease—KIT—germ cell cancer	0.000263	0.00172	CbGpPWpGaD
Orlistat—Nausea—Methotrexate—germ cell cancer	0.000256	0.000629	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—FGFR3—germ cell cancer	0.000242	0.00158	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—FGFR3—germ cell cancer	0.000242	0.00158	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—KIT—germ cell cancer	0.000222	0.00145	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—KIT—germ cell cancer	0.000222	0.00145	CbGpPWpGaD
Orlistat—PLA2G4A—PDGFR-beta signaling pathway—HRAS—germ cell cancer	0.000218	0.00142	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—SLC2A3—germ cell cancer	0.000208	0.00136	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—SLC22A3—germ cell cancer	0.000205	0.00134	CbGpPWpGaD
Orlistat—FASN—Disease—FGFR3—germ cell cancer	0.000203	0.00132	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—FGFR3—germ cell cancer	0.000201	0.00131	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	0.000198	0.00129	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—OXT—germ cell cancer	0.000198	0.00129	CbGpPWpGaD
Orlistat—FASN—Disease—KIT—germ cell cancer	0.000186	0.00121	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—KIT—germ cell cancer	0.000184	0.0012	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CRABP1—germ cell cancer	0.000167	0.00109	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—HRAS—germ cell cancer	0.000163	0.00106	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—HRAS—germ cell cancer	0.000163	0.00106	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	0.000163	0.00106	CbGpPWpGaD
Orlistat—PNLIP—Disease—MYC—germ cell cancer	0.000145	0.000944	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—AVP—germ cell cancer	0.000136	0.000885	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MYC—germ cell cancer	0.000122	0.000798	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MYC—germ cell cancer	0.000122	0.000798	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—OXT—germ cell cancer	0.000117	0.000763	CbGpPWpGaD
Orlistat—PNLIP—Disease—HRAS—germ cell cancer	0.000114	0.000742	CbGpPWpGaD
Orlistat—FASN—Disease—MYC—germ cell cancer	0.000102	0.000668	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MYC—germ cell cancer	0.000101	0.000661	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TP53—germ cell cancer	0.0001	0.000655	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TP53—germ cell cancer	0.0001	0.000655	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—FGF4—germ cell cancer	9.98e-05	0.000651	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—HRAS—germ cell cancer	9.61e-05	0.000627	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—HRAS—germ cell cancer	9.61e-05	0.000627	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—H2AFZ—germ cell cancer	8.91e-05	0.000581	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TP53—germ cell cancer	8.32e-05	0.000543	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—KITLG—germ cell cancer	8.2e-05	0.000535	CbGpPWpGaD
Orlistat—FASN—Disease—HRAS—germ cell cancer	8.04e-05	0.000525	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—AVP—germ cell cancer	8.01e-05	0.000523	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—HRAS—germ cell cancer	7.96e-05	0.000519	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—TP53—germ cell cancer	7.45e-05	0.000486	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—HRAS—germ cell cancer	7.13e-05	0.000465	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—FGFR3—germ cell cancer	6.09e-05	0.000397	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—KIT—germ cell cancer	5.59e-05	0.000365	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—SLC2A3—germ cell cancer	4.86e-05	0.000317	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—SLC22A3—germ cell cancer	4.79e-05	0.000313	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—HRAS—germ cell cancer	4.09e-05	0.000267	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CRABP1—germ cell cancer	3.91e-05	0.000255	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MYC—germ cell cancer	3.08e-05	0.000201	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TP53—germ cell cancer	2.53e-05	0.000165	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HRAS—germ cell cancer	2.42e-05	0.000158	CbGpPWpGaD
